Search

everythinglearnresearchcommunity

for

Search:↓

Progesterone reduces anxiety and depression in female mice by increasing BDNF in the brain, needing 5α-reduction and estradiol.

c-Kit is important for heart regeneration and cancer development.

Certain gene variations in the Vitamin D Receptor are linked to higher risk of female hair loss.

New shampoo with tyramine hydrochloride reduces hair loss by making a small muscle in the hair follicle contract.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

The PTGER2 gene is highly active in Cashmere goat skin and its activity changes with the hair growth cycle.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

RXRa is crucial for Th2 immune cell development and may link nutrition to immune health.

Inhibiting certain proteins harms hair follicle immunity and increases IL-33, affecting hair health.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

Lack of FPR2 slows hair growth by affecting hair cell activity.

The rs1128977 gene variant may affect cholesterol and body measurements.

Activating δ-opioid receptors can help hair grow.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

GLP-1RAs, like semaglutide and tirzepatide, may cause hair loss, so patients should be informed and monitored.

GLP-1RAs may cause hair loss but could also help regrow hair in some cases.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

GLP-1 receptor agonists may cause hair loss, but regrowth is rare.

GLP-1RA therapy may increase the risk of hair loss.

GLP-1 receptor agonists may cause hair loss, but more research is needed.

GLP-1 agonists may increase the risk of hair loss.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

RORA may help regulate hair growth by affecting hair follicle stem cells.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Gefitinib can cause scalp skin issues and permanent hair loss.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Lower PPARγ levels and specific gene variations are linked to more severe Frontal Fibrosing Alopecia.

Excessive sun protection might contribute to frontal fibrosing alopecia.

The vitamin D receptor helps maintain hair and bone health even without binding vitamin D.